4.5 Article

Quality assurance at the point-of-care: Noninvasively detecting vaccine freezing variability using water proton NMR

Journal

VACCINE
Volume 38, Issue 31, Pages 4853-4860

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2020.05.049

Keywords

Vaccine freezing; Aluminum adjuvant; WHO Shake Test; Cold chain; NMR

Funding

  1. Center of Excellence in Regulatory Science and Innovation (CERSI) from the US Food & Drug Administration [01FD005946]
  2. University of Maryland School of Pharmacy

Ask authors/readers for more resources

Aluminum-adjuvanted vaccines are freeze-sensitive products that require attentive cold chain adherence. Freeze/thaw events can be tested using The World Health Organization Shake Test, a qualitative test whereby a vial from the batch suspected to have been frozen is checked to infer whether the whole batch has been frozen. In this paper, we present a noninvasive and quantitative method to detect whether a vial of liquid vaccine has experienced freeze/thaw using the water proton transverse relaxation rate by Nuclear Magnetic Resonance relaxometry (wNMR relaxometry). Importantly, wNMR relaxometry does not compromise the vial's integrity so the analyzed vial can be used for vaccination if it meets the quality specifications. Vial-to-vial variability in freezing susceptibility within a single carton of vaccine vials was also detected, both by visual observation and concurrently by wNMR relaxometry. This variability brings into question the practice of using one or a few vials in a batch of vaccines to infer about the quality of the whole batch. (C) 2020 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available